Versant Capital Management’s Kindred Healthcare KND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-4,997
Closed -$44K 1747
2018
Q2
$44K Sell
4,997
-73
-1% -$654 0.02% 344
2018
Q1
$46K Sell
5,070
-81
-2% -$749 0.02% 322
2017
Q4
$49K Buy
5,151
+4,465
+651% +$33.2K 0.02% 310
2017
Q3
$4K Sell
686
-1,610
-70% -$13.7K ﹤0.01% 1141
2017
Q2
$26K Buy
2,296
+933
+68% +$9.2K 0.01% 492
2017
Q1
$11K Buy
1,363
+223
+20% +$1.75K 0.01% 827
2016
Q4
$8K Sell
1,140
-664
-37% -$5.45K ﹤0.01% 911
2016
Q3
$18K Sell
1,804
-1,826
-50% -$20.3K 0.01% 616
2016
Q2
$40K Sell
3,630
-39
-1% -$488 0.02% 302
2016
Q1
$45K Buy
3,669
+427
+13% +$4.43K 0.03% 262
2015
Q4
$38K Buy
+3,242
New +$42K 0.02% 302

Versant Capital Management's KND Position: Q3 2018 in Review

Versant Capital Management sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 4,997 shares — an estimated $44K sold.

Versant Capital Management first reported a position in KND in Q4 2015 and held it in 11 quarters. The position peaked at $49K in Q4 2017. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.

  • Versant Capital Management reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
  • Versant Capital Management sold 4,997 Kindred Healthcare shares in Q3 2018, an estimated $44K.
  • Versant Capital Management first reported a position in Kindred Healthcare in Q4 2015 and held it in 11 quarters.
  • Versant Capital Management's Kindred Healthcare position peaked at $49K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.

Based on Versant Capital Management's 13F filing for Q3 2018, filed 15 Oct 2018.